Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing
36100 total appearances

Appearances Over Time

Podcast Appearances

The Five
The Five 05-21-2025

One more thing is up next.

The Five
The Five 05-21-2025

You touched me with that. I'm going to watch that. I love that. You like that is a great thing. A Holocaust survivor's lifelong dream of going to college has finally come true. Ninety seven year old Jacqueline Kimmel still escaped Nazi Germany as a child, but never returned to school.

The Five
The Five 05-21-2025

You touched me with that. I'm going to watch that. I love that. You like that is a great thing. A Holocaust survivor's lifelong dream of going to college has finally come true. Ninety seven year old Jacqueline Kimmel still escaped Nazi Germany as a child, but never returned to school.

The Five
The Five 05-21-2025

Thanks to Golden Dreams program at her assisted living facility, Jacqueline became a student for a day at the University of Mount Sinai, Vincent in New York, attending classes, including English literature and earning her certificate of achievement. Congratulations to that young lady.

The Five
The Five 05-21-2025

Thanks to Golden Dreams program at her assisted living facility, Jacqueline became a student for a day at the University of Mount Sinai, Vincent in New York, attending classes, including English literature and earning her certificate of achievement. Congratulations to that young lady.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

One of the most successful of all time. It's up there from a financial perspective, but also just from a cultural impact perspective. It's one of the biggest deals. That's rare.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

One of the most successful of all time. It's up there from a financial perspective, but also just from a cultural impact perspective. It's one of the biggest deals. That's rare.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

One of the most successful of all time. It's up there from a financial perspective, but also just from a cultural impact perspective. It's one of the biggest deals. That's rare.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

Well, the company is Novo Nordisk, which is based in Denmark, and they've been around for about 100 years. Most of that time, probably a lot of Americans never heard of it.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

Well, the company is Novo Nordisk, which is based in Denmark, and they've been around for about 100 years. Most of that time, probably a lot of Americans never heard of it.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

Well, the company is Novo Nordisk, which is based in Denmark, and they've been around for about 100 years. Most of that time, probably a lot of Americans never heard of it.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

Last year, their combined sales of just those two drugs were over $26 billion. Wow. For Ozempic, I think it was up about 25% from the year before. So on paper, the company is still growing tremendously.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

Last year, their combined sales of just those two drugs were over $26 billion. Wow. For Ozempic, I think it was up about 25% from the year before. So on paper, the company is still growing tremendously.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

Last year, their combined sales of just those two drugs were over $26 billion. Wow. For Ozempic, I think it was up about 25% from the year before. So on paper, the company is still growing tremendously.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

The CEO of Novo Nordisk for the past eight years is leaving the company.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

The CEO of Novo Nordisk for the past eight years is leaving the company.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

The CEO of Novo Nordisk for the past eight years is leaving the company.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

This is not part of an orderly plan for him to go spend time on the beach and enjoy retirement. This was not his choice. He's essentially being pushed out.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

This is not part of an orderly plan for him to go spend time on the beach and enjoy retirement. This was not his choice. He's essentially being pushed out.

The Journal.
Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

This is not part of an orderly plan for him to go spend time on the beach and enjoy retirement. This was not his choice. He's essentially being pushed out.

← Previous Page 145 of 1805 Next →